Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Sify Technologies Q4 IFRS Loss Narrows - Quick Facts

RELATED NEWS
Trade SIFY now with 

Sify Technologies Ltd. (SIFY: Quote) posted fourth-quarter IFRS net loss of INR 60 million versus loss of INR 108 million last year.

Revenue for the quarter climbed to INR 1.86 billion from INR 1.71 billion in the prior year.

MP Vijay Kumar, chief financial officer, said, "Our continued focus onoptimising cost, while retaining our growth momentum, is yielding positive results. Operating cash flow continues to be positive and gross margins have remained steady, in spite of continuing pricing pressure in the market. As a result, we are seeing a consistent contribution to our EBITDA from both existing and new value-added services we have introduced."

Click here to receive FREE breaking news email alerts for Sify Technologies Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.